Diethylstilbestrol

己烯雌酚

Report date: 2023/02/27 20:00:18
NME

Base Information

Drug NameDiethylstilbestrol
Drug Alias Name二乙基乙烯雌酚StilbestrolStilboestrol乙烯雌酚已烯雌酚 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors agonists
TargetsEstrogen receptors
Therapy Area/IndicationsOestrogen deficiency symptomsBreast Milk ExpressionArterial Occlusive Diseases +[5] 
Global Approved IndicationsOestrogen deficiency symptomsBreast Milk ExpressionProstatic Neoplasms +[4] 
Approved Indications in ChinaOestrogen deficiency symptomsBreast Milk ExpressionProstatic Neoplasms +[4] 
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomGreece +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesUniversity Of Patras
China Registration ClassN/A

Develop Information

Active CompaniesTeva Uk LtdTianjin Lisheng Pharmaceutical Co Ltd
Inactive CompaniesUniversity Of Patras
Active IndicationsOestrogen deficiency symptomsBreast Milk ExpressionProstatic Neoplasms +[4] 
Inactive IndicationsArterial Occlusive Diseases

Other Information

ATC CodeG03CB02G03CC05L02AA01
Related LinksWikipediaDrugBankKEGG